Home › Non-Small Cell Lung Cancer
Pag-aaral pangklinika para sa Non-Small Cell Lung Cancer na nagre-recruit sa U.S.
438 pag-aaral para sa Non-Small Cell Lung Cancer ang nagre-recruit ng mga kalahok sa mga site sa buong Estados Unidos.
Mga lungsod na may pinakamaraming pag-aaral
- Houston, TX143 pag-aaral
- New York City, NY123 pag-aaral
- Arlington, VA111 pag-aaral
- Nashville, TN97 pag-aaral
- Los Angeles, CA92 pag-aaral
- Boston, MA87 pag-aaral
- St. Louis, MO68 pag-aaral
- Baltimore, MD60 pag-aaral
- San Antonio, TX60 pag-aaral
- Chicago, IL59 pag-aaral
- Columbus, OH57 pag-aaral
- Seattle, WA55 pag-aaral
- Washington, DC55 pag-aaral
- Tampa, FL53 pag-aaral
- Dallas, TX53 pag-aaral
- Edison, NJ50 pag-aaral
- Philadelphia, PA49 pag-aaral
- Portland, OR49 pag-aaral
- San Diego, CA49 pag-aaral
- Queens, NY49 pag-aaral
- Cleveland, OH48 pag-aaral
- Atlanta, GA48 pag-aaral
- Pittsburgh, PA47 pag-aaral
- Orlando, FL47 pag-aaral
- Grand Rapids, MI46 pag-aaral
- Santa Monica, CA45 pag-aaral
- Durham, NC42 pag-aaral
- Jacksonville, FL41 pag-aaral
- New Haven, CT40 pag-aaral
- Detroit, MI40 pag-aaral
- Rochester, MN38 pag-aaral
- San Francisco, CA37 pag-aaral
- Baldwin Park, CA36 pag-aaral
- Miami, FL35 pag-aaral
- Indianapolis, IN32 pag-aaral
- Oklahoma City, OK32 pag-aaral
- Cincinnati, OH31 pag-aaral
- Aurora, CO31 pag-aaral
- Salt Lake City, UT31 pag-aaral
- Irvine, CA30 pag-aaral
Ayos sa estado
- Alabama36 pag-aaral
- Alaska13 pag-aaral
- Arizona67 pag-aaral
- Arkansas34 pag-aaral
- California210 pag-aaral
- Colorado72 pag-aaral
- Connecticut54 pag-aaral
- Delaware20 pag-aaral
- District of Columbia38 pag-aaral
- Florida164 pag-aaral
- Georgia73 pag-aaral
- Hawaii12 pag-aaral
- Idaho19 pag-aaral
- Illinois91 pag-aaral
- Indiana48 pag-aaral
- Iowa29 pag-aaral
- Kansas32 pag-aaral
- Kentucky45 pag-aaral
- Louisiana24 pag-aaral
- Maine16 pag-aaral
- Maryland75 pag-aaral
- Massachusetts99 pag-aaral
- Michigan99 pag-aaral
- Minnesota71 pag-aaral
- Mississippi20 pag-aaral
- Missouri83 pag-aaral
- Montana17 pag-aaral
- Nebraska40 pag-aaral
- Nevada22 pag-aaral
- New Hampshire17 pag-aaral
- New Jersey90 pag-aaral
- New Mexico21 pag-aaral
- New York167 pag-aaral
- North Carolina80 pag-aaral
- North Dakota16 pag-aaral
- Ohio123 pag-aaral
- Oklahoma35 pag-aaral
- Oregon62 pag-aaral
- Pennsylvania100 pag-aaral
- Rhode Island14 pag-aaral
- South Carolina31 pag-aaral
- South Dakota20 pag-aaral
- Tennessee120 pag-aaral
- Texas213 pag-aaral
- Utah53 pag-aaral
- Vermont8 pag-aaral
- Virginia145 pag-aaral
- Washington85 pag-aaral
- West Virginia16 pag-aaral
- Wisconsin44 pag-aaral
Mga pag-aaral na kamakailan lamang in-update
Opisyal na teksto ng pag-aaral (English)
A Study Evaluating Sotorasib Platinum Doublet Combination Versus Pembrolizumab Platinum Doublet Combination as a Front-Line Therapy in Participants With Stage IV or Advanced Stage IIIB/C Nonsquamous Non-Small Cell Lung Cancers (CodeBreaK 202)
Nagre-recruitPhase 3
Edad 18 hanggang 100 · Lahat ng kasarian · Na-update Nob 13, 2026 · NCT05920356A Study of ASP546C in Adults With Gastroesophageal Cancer, Pancreatic Cancer or Other Solid Tumors
Nagre-recruitPhase 1/2
Edad 18 pataas · Lahat ng kasarian · Na-update Nob 13, 2026 · NCT07488676A Phase 2 Study of VS-7375 in Patients With KRAS G12D-Mutated Non-Small Cell Lung Cancer
Nagre-recruitPhase 2
Edad 18 pataas · Lahat ng kasarian · Na-update Nob 13, 2026 · NCT07659782A Clinical Trial to Test if an Investigational Combination Therapy With BNT326 and BNT327 is Safe and Potentially Beneficial for People With Advanced Non-small Cell Lung Cancer (NSCLC)
Nagre-recruitPhase 1/2
Edad 18 pataas · Lahat ng kasarian · Na-update Nob 13, 2026 · NCT07111520Study of Izalontamab Brengitecan (BMS-986507) Versus Platinum-based Chemotherapy With or Without Amivantamab for EGFR-mutated Non-small Cell Lung Cancer After Failure of EGFR TKI Therapy (IZABRIGHT-Lung01)
Nagre-recruitPhase 2/3
Edad 18 pataas · Lahat ng kasarian · Na-update Nob 12, 2026 · NCT07100080A Clinical Study of Calderasib (MK-1084) and Other Treatments for Participants With Non-Small Cell Lung Cancer (MK-1084-007/KANDLELIT-007)
Nagre-recruitPhase 3
Edad 18 pataas · Lahat ng kasarian · Na-update Nob 12, 2026 · NCT07190248This is a Study to Learn About How the Combination of the Study Medicines Sigvotatug Vedotin Plus Pembrolizumab Works in People With Non-small Cell Lung Cancer With High Levels of PD-L1.
Nagre-recruitPhase 3
Edad 18 pataas · Lahat ng kasarian · Na-update Nob 12, 2026 · NCT06758401A Clinical Trial of Calderasib (MK-1084) and Durvalumab in People With Non-Small Cell Lung Cancer (MK-1084-015/KANDLELIT-015)
Nagre-recruitPhase 3
Edad 18 pataas · Lahat ng kasarian · Na-update Nob 12, 2026 · NCT07554339Immunotherapy After Surgery for People Who Have No Remaining Cancer Cells After Standard Treatment for Early-Stage Non-Small Cell Lung Cancer, INSIGHT Trial
Nagre-recruitPhase 3
Edad 18 pataas · Lahat ng kasarian · Na-update Nob 12, 2026 · NCT06498635BostonGene and Exigent Genomic INsight Study
Nagre-recruitObservasyonal na pag-aaral
Edad 18 pataas · Lahat ng kasarian · Na-update Nob 12, 2026 · NCT06272864Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer, an ALCHEMIST Treatment Trial (Chemo-IO [ACCIO])
Nagre-recruitPhase 3
Edad 18 pataas · Lahat ng kasarian · Na-update Nob 12, 2026 · NCT04267848A Phase 2 Platform Study of Immunomodulatory Compounds in ICI-refractory Non-small Cell Lung Cancer
Nagre-recruitPhase 2
Edad 18 pataas · Lahat ng kasarian · Na-update Nob 12, 2026 · NCT07133425A Phase 1 Study of PLN-101095 in Adults With Advanced or Metastatic Solid Tumors
Nagre-recruitPhase 1
Edad 18 pataas · Lahat ng kasarian · Na-update Nob 12, 2026 · NCT06270706A KRAS Inhibitor in Participants With Advanced Solid Tumors
Nagre-recruitPhase 1/2
Edad 18 pataas · Lahat ng kasarian · Na-update Nob 12, 2026 · NCT07912593A Study of Calderasib (MK-1084) Plus Pembrolizumab (MK-3475) in Participants With KRAS G12C Mutant Non-small Cell Lung Cancer (NSCLC) With Programmed Cell Death Ligand 1 (PD-L1) Tumor Proportion Score (TPS) ≥50% (MK-1084-004/KANDLELIT-004)
Nagre-recruitPhase 3
Edad 18 pataas · Lahat ng kasarian · Na-update Nob 12, 2026 · NCT06345729Biospecimen Procurement for Center for Immuno-Oncology Immunotherapy Protocols
Nagre-recruitObservasyonal na pag-aaral
Edad 18 hanggang 120 · Lahat ng kasarian · Na-update Nob 12, 2026 · NCT02682667Trial of Therapeutic Cancer Vaccine OSE2101 in Patients With Non-Small Cell Lung Cancer and Secondary Resistance to Immune Checkpoint Inhibitor
Nagre-recruitPhase 3
Edad 18 pataas · Lahat ng kasarian · Na-update Nob 12, 2026 · NCT06472245Beamion LUNG-1: A Study to Test Different Doses of Zongertinib in People With Different Types of Advanced Cancer (Solid Tumours With Changes in the HER2 Gene)
Nagre-recruitPhase 1
Edad 18 pataas · Lahat ng kasarian · Na-update Nob 12, 2026 · NCT04886804A Study of PRMT5 Inhibitor BAY 3713372 in Participants With MTAP-deleted Solid Tumors
Nagre-recruitPhase 1/2
Edad 18 pataas · Lahat ng kasarian · Na-update Nob 12, 2026 · NCT06914128A Phase 1/2 Study of VS-7375 in Patients With KRAS G12D-Mutated Solid Tumors
Nagre-recruitPhase 1/2
Edad 18 pataas · Lahat ng kasarian · Na-update Nob 10, 2026 · NCT07020221A Study to Assess Efficacy and Safety of Pembrolizumab With or Without Sacituzumab Tirumotecan (MK- 2870) in Adult Participants With Resectable Non Small Cell Lung Cancer (NSCLC) Not Achieving Pathological Complete Response (pCR) (MK-2870-019)
Nagre-recruitPhase 3
Edad 18 pataas · Lahat ng kasarian · Na-update Nob 10, 2026 · NCT06312137A Study of DS-3939a in Participants With Solid Tumors
Nagre-recruitPhase 1/2
Edad 18 pataas · Lahat ng kasarian · Na-update Nob 10, 2026 · NCT07739966Study to Test the Safety and Tolerability of PF-07220060 in Participants With Advance Solid Tumors
Nagre-recruitPhase 2
Edad 18 pataas · Lahat ng kasarian · Na-update Nob 10, 2026 · NCT04557449A Study to Assess the Efficacy of WSD0922-FU in Patients With C797S+ Advanced Non-small Cell Lung Cancer
Nagre-recruitPhase 2
Edad 18 pataas · Lahat ng kasarian · Na-update Nob 10, 2026 · NCT06868485A Study of IDE034 in Adult Participants With Locally Advanced/Metastatic Solid Tumors Types
Nagre-recruitPhase 1
Edad 18 pataas · Lahat ng kasarian · Na-update Nob 10, 2026 · NCT07503808Mula sa ClinicalTrials.gov, na-kuha noong Nob 15, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.